Ghana: Commercialisation of genetically modified poses significant risks and uncertainties

Published 2024년 4월 11일

Tridge summary

The Centre for Climate Change and Food Security (CCCFS) has expressed strong opposition to the Ghana National Biosafety Authority's approval of 14 genetically modified (GM) products, including varieties of maize and soybean. While recognizing the potential agricultural benefits of biotechnology, CCCFS highlights concerns over the risks and uncertainties of GM products, emphasizing not just health and environmental impacts but also socio-economic consequences. The organization advocates for a cautious approach to adopting GM technology, urging for sustainable agricultural practices that prioritize resilience, equity, and the well-being of both present and future generations.

Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

The Centre for Climate Change and Food Security (CCCFS) has expressed its opposition to the decision by the Ghana National Biosafety Authority (NBA) to approve the commercialisation of 14 novel genetically modified (GM) products, comprising eight maize and six soybean products. In a press release from CCCFS, it said while it recognises the potential of biotechnology to address certain agricultural challenges, it firmly believes that the commercialisation of GM products poses significant risks and uncertainties that cannot be overlooked. The Centre argued that “these risks extend beyond concerns about human health and environmental impact to encompass broader socio-economic implications.” CCCFS in its press release on the matter has called for greater caution and prudence in the adoption of GM technology while urging government and regulatory authorities to prioritize the precautionary principle and exercise due diligence in evaluating the risks and benefits associated with GM ...

Source: Modernghana